Results 141 to 150 of about 4,939,312 (268)
Effect of Doping on the Electronic Structure of the Earth's Lower Mantle Compounds: FeXO3 with X = C, Al, Si. [PDF]
Chernov ED, Dyachenko AA, Lukoyanov AV.
europepmc +1 more source
Summary Glofitamab was investigated with obinutuzumab/rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone (G/R‐CHOP) in patients with relapsed/refractory B‐cell non‐Hodgkin lymphoma (B‐NHL) who had ≥1 prior obinutuzumab/rituximab‐containing therapy (NCT03467373). The primary end‐point was to determine the optimal biological dose of
William Townsend +16 more
wiley +1 more source
Compositions of gneisses from the Early Precambrian crystalline complexes of the Aldan shield and of mantle xenoliths from kimberlites plot along the magmatic fractionation trends.
Vladimir S. Shkodzinskii
doaj
Mineralogy of the deep lower mantle in the presence of H2O. [PDF]
Hu Q +7 more
europepmc +1 more source
Dispersal, source and glass chemistry of a third tephra unit within Iceland's Settlement Layer
Tephra layers may be studied to understand the dynamics and sequence of past explosive volcanism. In Iceland, the distinctive Settlement Layer (AD ~877) underlies almost all archaeological evidence for the Norse Settlement and is preserved in soils across Iceland and as cryptotephra overseas.
Conner A. G. Morison +3 more
wiley +1 more source
Linking rates of slab sinking to long-term lower mantle flow and mixing [PDF]
Numerical models of Earth's mantle dynamics that aim to comply with a variety of surface observations and/or modern mantle structure, still predict a widely varying vigour of mantle flow which governs the long-term evolution of mantle structure and ...
Spakman, Wim +3 more
core
Covalent drug discovery: Progress against key targets, emerging strategies and lessons learnt
Abstract Covalent drug discovery is currently experiencing a boom in industrial and academic interest. To date, at least 75 covalent drugs have received regulatory approval, targeting both traditional target classes and more challenging proteins for which other approaches failed. In many cases, unique aspects of covalent targeting are essential for the
Charles P. Brown +2 more
wiley +1 more source
Bruton tyrosine kinase inhibitors and cardiovascular adverse events
Abstract Bruton tyrosine kinase inhibitors (BTKi) have transformed the management of chronic lymphocytic leukaemia and other B‐cell malignancies, yet their therapeutic benefit is tempered by clinically relevant cardiovascular toxicities (predominantly atrial fibrillation, hypertension, bleeding and ventricular arrhythmias).
Massimiliano Camilli +4 more
wiley +1 more source
Rheology of the lower mantle: an alternative review. [PDF]
Cordier P, Van Orman J, Carrez P.
europepmc +1 more source

